Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-06-19 @ 6:57 PM
Study NCT ID:
NCT04745832
Status:
TERMINATED
Last Update Posted:
2024-11-04
First Post:
2021-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)
Sponsor:
MEI Pharma, Inc.
Organization: